GB2625740A - The production of postbiotics from fermented pot ale and brewers spent grain - Google Patents
The production of postbiotics from fermented pot ale and brewers spent grain Download PDFInfo
- Publication number
- GB2625740A GB2625740A GB2219520.0A GB202219520A GB2625740A GB 2625740 A GB2625740 A GB 2625740A GB 202219520 A GB202219520 A GB 202219520A GB 2625740 A GB2625740 A GB 2625740A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pot ale
- fermentation
- lactobacillus
- yeast
- ale
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- 239000004458 spent grain Substances 0.000 title claims description 64
- 238000000855 fermentation Methods 0.000 claims abstract description 73
- 230000004151 fermentation Effects 0.000 claims abstract description 73
- 239000012141 concentrate Substances 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 44
- 239000000047 product Substances 0.000 claims abstract description 29
- 150000003839 salts Chemical class 0.000 claims abstract description 26
- 241001474374 Blennius Species 0.000 claims abstract description 22
- 239000006041 probiotic Substances 0.000 claims abstract description 22
- 235000018291 probiotics Nutrition 0.000 claims abstract description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 21
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000679 carrageenan Substances 0.000 claims abstract description 20
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 20
- 229920001525 carrageenan Polymers 0.000 claims abstract description 20
- 229940113118 carrageenan Drugs 0.000 claims abstract description 20
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 20
- 108090000790 Enzymes Proteins 0.000 claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 claims abstract description 16
- 108010009736 Protein Hydrolysates Proteins 0.000 claims abstract description 16
- 239000003531 protein hydrolysate Substances 0.000 claims abstract description 16
- 235000015041 whisky Nutrition 0.000 claims abstract description 16
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 239000012065 filter cake Substances 0.000 claims abstract description 13
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 10
- 230000000529 probiotic effect Effects 0.000 claims abstract description 10
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 9
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 230000002519 immonomodulatory effect Effects 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims abstract description 6
- 240000006677 Vicia faba Species 0.000 claims abstract description 5
- 235000010749 Vicia faba Nutrition 0.000 claims abstract description 5
- 235000002098 Vicia faba var. major Nutrition 0.000 claims abstract description 5
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 5
- 235000019704 lentil protein Nutrition 0.000 claims abstract description 5
- 239000011148 porous material Substances 0.000 claims abstract description 5
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 239000012138 yeast extract Substances 0.000 claims abstract description 5
- 238000005119 centrifugation Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 102000003814 Interleukin-10 Human genes 0.000 claims abstract 2
- 108090000174 Interleukin-10 Proteins 0.000 claims abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 33
- 230000012010 growth Effects 0.000 claims description 26
- 230000001580 bacterial effect Effects 0.000 claims description 25
- 239000004310 lactic acid Substances 0.000 claims description 19
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 241000186660 Lactobacillus Species 0.000 claims description 17
- 229940039696 lactobacillus Drugs 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 12
- 230000002538 fungal effect Effects 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 241000894007 species Species 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 6
- 238000010563 solid-state fermentation Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 241000186216 Corynebacterium Species 0.000 claims description 2
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 2
- 108700012920 TNF Proteins 0.000 claims description 2
- 235000020299 breve Nutrition 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 241000186679 Lactobacillus buchneri Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 25
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 17
- 244000199866 Lactobacillus casei Species 0.000 abstract description 8
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract description 7
- 241000186226 Corynebacterium glutamicum Species 0.000 abstract description 5
- 241000233866 Fungi Species 0.000 abstract description 5
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 4
- 240000001929 Lactobacillus brevis Species 0.000 abstract description 4
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 3
- 241000186426 Acidipropionibacterium acidipropionici Species 0.000 abstract description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 abstract description 2
- 229940017800 lactobacillus casei Drugs 0.000 abstract description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 36
- 238000002474 experimental method Methods 0.000 description 30
- 239000002609 medium Substances 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 244000005700 microbiome Species 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 15
- 235000015097 nutrients Nutrition 0.000 description 13
- 235000020183 skimmed milk Nutrition 0.000 description 11
- 230000007407 health benefit Effects 0.000 description 10
- 239000002054 inoculum Substances 0.000 description 10
- 238000013019 agitation Methods 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 239000002699 waste material Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 235000013406 prebiotics Nutrition 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000009469 supplementation Effects 0.000 description 6
- 235000019583 umami taste Nutrition 0.000 description 6
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 5
- 235000019705 chickpea protein Nutrition 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 235000019703 fava protein Nutrition 0.000 description 4
- 239000012263 liquid product Substances 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000219739 Lens Species 0.000 description 3
- 241000736262 Microbiota Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000001965 potato dextrose agar Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000020092 scotch whiskey Nutrition 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 239000001974 tryptic soy broth Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 240000004322 Lens culinaris Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- 241000191998 Pediococcus acidilactici Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 241000235088 Saccharomyces sp. Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007358 intestinal barrier function Effects 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000002636 mycotoxin Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000004460 silage Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- LMRJHNFECNKDKH-UHFFFAOYSA-N 4-(trifluoromethyl)nicotinic acid Chemical compound OC(=O)C1=CN=CC=C1C(F)(F)F LMRJHNFECNKDKH-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000512260 Ascophyllum Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008846 dynamic interplay Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 244000078673 foodborn pathogen Species 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000008102 immune modulation Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- MSXHSNHNTORCAW-MPGIDXPLSA-M sodium;(3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].O[C@@H]1OC(C([O-])=O)[C@@H](O)[C@H](O)[C@@H]1O MSXHSNHNTORCAW-MPGIDXPLSA-M 0.000 description 1
- RIRRNZUBFFOHHQ-UHFFFAOYSA-M sodium;phosphoric acid;acetate Chemical compound [Na+].CC([O-])=O.OP(O)(O)=O RIRRNZUBFFOHHQ-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000034216 susceptibility to 2 bacteremia Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
- A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12F—RECOVERY OF BY-PRODUCTS OF FERMENTED SOLUTIONS; DENATURED ALCOHOL; PREPARATION THEREOF
- C12F3/00—Recovery of by-products
- C12F3/10—Recovery of by-products from distillery slops
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A method of producing a postbiotic comprising: (a) obtaining liquid pot ale from whisky production in the absence of enzymes; (b) concentrating the pot ale by reverse osmosis with 0.0002 micron or less pore size membrane to produce a fermentation medium; (c) inoculating the fermentation medium with probiotic bacteria, yeast, and/or fungus; (d) incubating; and (e) raising the temperature of the incubated pot ale to a temperature to kill the probiotic bacteria/yeast/fungus. The pot ale may be clarified before step (b) by mixing with aqueous carrageenan, centrifugation, or whirlpooling. The probiotic bacteria/yeast/fungus may be selected from Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus brevis, Paediococcus acidilactici, Saccharomyces cerevisiae, Aspergillus oryzae, Corynebacterium glutamicum, Propionibacterium acidipropionici. Salts, surfactants, nitrogen sources, seaweed filter cake, yeast extract, and protein hydrolysate (e.g. from chickpea, fava bean, or lentil protein concentrate) may be added to the fermentation medium. Step (d) may be primary or submerged fermentation. The postbiotic may be mixed with additional products, such as Aquamin, milled seaweed, foodstuff, or animal feed. The postbiotic product may have immunomodulatory properties e.g. increasing IL10 levels and decreasing TNFα levels.
Description
The Production of Postbiotics from Fermented pot ale and Brewers spent grain
Field of the Invention
The invention relates to methods of producing postbiotics from waste materials resulting from the production of whisky and to the postbiotics produced by these processes.
Background to the Invention
The microbial habitat within the animal/human gastrointestinal tract is the site of a complex and dynamic mutualistic relationship between the gut microbiota and the host. The human body provides a stable, nutrient-rich environment for those microorganisms, and in return, receives several benefits. These benefits include stimulation of the immune system, improved digestion and absorption of food" reduced growth of pathogenic flora., and maintenance of intestinal barrier integrity. The members of the gut microbiota also produce a wide range of compounds that can be used by both the host and by other microorganisms. This dynamic interaction between the host and its microbiota is essential for achieving and maintaining host homoeostasis and health.
The composition and function of the gastrointestinal microbiota can be modulated in numerous ways. Prebiotics, probiotics and postbiotics can modulate the structure and metabolic activities of the microbial community. Prebiotics are defined as "a substrate that is selectively utilized by host microorganisms conferring a health benefit". The following criteria are used to classify a compound as a prebiotic: (i) it should be resistant to acidic pH of stomach, cannot be hydrolyzed by mammalian enzymes, and also should not be absorbed in the gastrointestinal tract, (ii) it can be fermented by intestinal microbiota, and (iii) the growth and/or activity of the intestinal bacteria can be selectively stimulated by this compound and this process improves host's health. Prebiotics have an established role in the promotion of human health due to their beneficial effects with a range of diseases including cardiovascular disease, gastrointestinal disorders, diabetes, colorectal cancer, obesity and allergies. The potential of prebiotics as dietary supplements in animals has been explored with regard to their ability to enhance growth performance and limit intestinal colonisation by animal and foodborne pathogens via their promotion of beneficial bacterial genera and their metabolic products in the GIT microbiota.
Probiotics are "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host". Probiotics have numerous advantageous functions in humans and animals, with the most notable being their ability to prevent pathogens from adhering to the intestinal surface through the production of antimicrobial substances and competitive exclusion, as well as maintaining the epithelial barrier, and modulating the immune system. Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus, Bifidobacterium, Saccharomyces, Enterococcus"ctreptococcus, Pediococcus, Bacillus and 13:scherichia coll. While probiotics are by definition alive and require an efficacious number of viable bacteria at the time of administration to the host, most probiotic preparations will include a large proportion of inanimate microbes, particularly towards the end of shelf life. Maintaining stability of live bacteria in foods is a challenge as many probiotic organisms are sensitive to certain food characteristics (acidity, water activity, specific chemical compounds) or storage conditions (moisture, temperature, package permeability to oxygen, time).
Cell viability has long been regarded as the most important parameter for the efficacy and quality of probiotics to confer a health benefit. However, recently there has been increased interest in inanimate microorganisms, their cell components and metabolites and their potential health benefits. Regarding the use of these inanimate microorganisms and their metabolites, several different terminologies have been used over the years such as non-viable probiotics, heat-killed probiotics, cell lysates, paraprobiotics, inactivated probiotics and postbiotics. As of 2021, a definition of postbiotics was proposed by the International Scientific Association of Probiotics and Prebiotics (ISAPP), stating that a postbiotic is a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". In simple terms, postbiotics can be described as bioactive compounds produced during a fermentation process (including inactive microbial cells, cell constituents, and metabolites) that provide a health benefit. A microbe can only be regarded as a postbiotic if it is properly characterized, deliberately prepared with a reproducible method for inactivation, and shown to confer a health benefit. Thus, a probiotic microorganism that gradually loses cell viability in food does not gradually become a postbiotic at the end of its shelf life.
The use of postbiotics is gaining increased attention because the administration of dead or inactivated microorganisms exerts many benefits over the use of live microorganisms. While probiotics have a range of health benefits, probiotic bacteria isolated from several commercially available dietary supplements have been shown to harbor resistance toward a range of antibiotics. There is also concern that these live bacteria may translocate from the gut lumen to the blood, thereby increasing susceptibility to bacteremia, especially in immunocompromised and vulnerable individuals. To address such issues, postbiotic components derived from probiotics may be a favourable and promising alternative.
Postbiotics are often more stable and convenient to include in consumer products compared to probiotics. As postbiotics contain inanimate microorganisms, cell viability is not an issue. Postbiotics are generally stable at room temperature, and they can be applied to many product forms, offering formulators greater flexibility. This may also be of particular interest for consumers in geographical regions that do not have reliable cold storage or whose temperate climates causes problems for storage of live bacteria.
Pot ale and brewers spent grain are nutrient rich co-products of whisky production which to date, have yet to be considered for use in the development of postbiotics. However, the use of these low-cost waste material as a fermentation media could offer great opportunity. The Scotch whisky definition prohibits the use of added enzymes. If enzymes are prohibited in whisky production, pot ale from such whisky production has a higher residual carbohydrate concentration compared to pot ale from other distilleries which use enzymes in manufacture. Fermenting pot ale in the presence of a culture of Lactic acid bacteria, for example, will provide a fermented product not only containing lactic acid bacteria, but also fermentation-derived metabolites that exert an array of health benefits for humans and animals.
The production of single malt-based spirits, such as Scotch whisky is an important sector of the economy. The production of whisky varies depending on the type and proportion of the cereals used as raw materials and the country it originates. A characteristic feature of Scotch single malt whisky is that the only cereal used in its manufacture is malted barley. Scotch whisky production generates a significant amount of co-products. The main co-products from malt whisky are draff (brewers spent grain), the residual starch-depleted grains remaining after the mashing step, pot ale, the liquid residue from the first distillation step, and spent lees from subsequent distillations. An overview of the malt whisky production process including generation of co-products is illustrated in Figure 1.
The co-products of the manufacture of malt whisky therefore comprise draff, pot ale and spent lees. The production of 1 L of alcohol yields approximately 2.5 kg of draff (brewers spent grain), 8 L of pot ale, and 10 L of spent lees (and washings). A large proportion of these co-products are used as fertiliser for animal feed, whilst the remainder requires disposal which incurs cost to the distillery along with the negative impact on the carbon footprint due to transportation. Brewers spent grain (BSG) is a rich source of fibre, protein and phenolic compounds, however due to its complex composition, high moisture content and fast deterioration, it is often underutilized as animal feed.
Pot ale consists of yeast, yeast and barley residues, soluble protein and carbohydrate, and copper. A proportion of pot ale is fed to animals, mainly pigs, whilst the remainder is used as feedstock for anaerobic digestion or consensually disposed of on the land/ sea which comes at a cost to the distillery. Large volumes of BSG and pot ale are generated by the brewing process all year round and at a low cost. These properties, together with its high nutritive value, have increased the exploration of alternative uses of B SG and pot ale which may encompass economic benefits.
Pot ale and BSG are nutrient rich co-products of whisky production which to date, have yet to be considered for use in the development of postbiotics. However, the use of these low-cost waste materials as a fermentation media could offer great opportunity.
Single strain and multi-strain postbiotics will be developed from these microorganisms which will have a range of applications in human and animals as outlined in Table 1. Raw pot ale is collected from distilleries and can be pre-treated with Carrageenan and the resulting material is used as a fermentation medium. During the fermentation, salts, surfactants and nitrogen sources are added and pH, temperature, inoculum and fermentation time is optimised to achieve high viable cell counts and growth. A complex mixture of metabolic products are secreted by bacteria during the fermentation such as enzymes, secreted proteins, short chain fatty acids, vitamins, secreted bacteriocins, amino acids, peptides, organic acids, etc. These microbial metabolites have a range of health promoting effects including anti-inflammatory, antibacterial, immunomodulator and antioxidant properties that enhance both the immune system and intestinal barrier functions by acting directly on specific tissues of the intestinal epithelium, but also on various organs/tissues.
Table 1. Suitable microorganisms for use in the process and their applications Microorganisms Process Application Bacteria Lactic acid bacteria (Approximately 14 strains) Addition of salts, surfactants and nitrogen sources from products within the company to improve viable cell counts. Aswell as optimising pH, temperature, inoculum, fermentation time. -Silage additives -Postbiotic liquid product -Inoculum for BSG solid state fermentation -Mycotoxin binder -Methane mitigation Propionic bacteria -Silage additives -Postbiotic liquid product Corynebacterium glutamicum -Glutamate (umami) -Postbiotic liquid product -Other amino acids Fungus Aspergillus oryzae(KOJI) " -Postbiotics -Enzymes (amylase, proteases etc.,) -Food applications Yeast Saccharomyces sp. -Postbiotic liquid product -Mycotoxin binder -Growth Ingredients Object of the Invention The object of the invention is to develop a process for the growth of microorganisms using pot ale from the whisky industry, particularly for whisky made without the use of enzymes. These microorganisms include approximately 14 EFSA registered lactic acid bacteria strains (available from Marigot Ltd), propionic bacteria, Corynebacterium glutamicum (C. glutamicum), Aspergillus oryzae (KOJI) and Saccharomyces sp. It is an object to develop single strain and multi-strain postbiotics these microorganisms which will have a range of applications in human and animals. A further object of the invention is to utilise waste products or by-products of other industries to produce value added products. A still further object of the invention is to provide novel postbiotics with a variety of advantageous properties such as anti-inflammatory and immunomodulatory properties.
Summary of the Invention
According to the present invention there is provided a method of producing a postbiotic comprising the steps: (a) obtaining a liquid pot ale from the production of whisky in the absence of enzymes, (b) concentrating the pot ale by reverse osmosis using a membrane with a pore size of about 0.0002 micron or less to produce a fermentation medium, (c) inoculating the raw, concentrated pot ale from step (b) with one or more probiotic bacterial and/or yeast and/or fungal strains, (d) incubating the inoculated pot ale at a temperature which is appropriate to promote growth of the particular bacterial, yeast or fungal strains used in step (c), for between 15 and 30 hours, (e) harvesting the bacterial biomass from the product of step (d) and subjecting the biomass to heat treatment at temperatures of 80 -90.0 for 90 -120 minutes to kill the bacterial, yeast or fungal strains.
Suitably the reverse osmosis membrane has a pore size of about 0.0001 micron or less.
The liquid pot ale may be clarified before concentration in step (b) by mixing it with an aqueous solution of carrageenan. The aqueous solution of carrageenan ensures removal of any insoluble particles such as yeast cells and suspended solids from the pot ale. Alternatively the pot ale may be clarified by centrifugation.
Preferably the heat-killed bacterial biomass is resuspended in cell-free fermented pot ale, which is then is sprayed onto mechanically or chemically processed seaweed to achieve the final product which contains a desired cell count of approximately 10 CFU/g.
The bacterial strains may be selected from homofermentative and heterofennentative lactic acid bacterial group Lactobacillus species, Paediococcus species. Aspergilhts species, Saccharomyces species, Propionicbacterium species, Cotynebacterium.species and the Lactic acid bacterial strains (EFSA approved):-Lactobacillus. case, Lactobacilhts rhainnosus, Lactobacillus breris -2 strains, Paediococcus pento.saceus -3 strains, Paediococcus acidilactici, Lactobacillus rhamnosus, Lactobacillus jertnenhun, Lactobacillus plantarum -3 strains, Lactobacillus paracasei, Paediococcus parimlus, Laciobacilhis &whiter' -2 strains, and Enetrococcu.sfaecium.
In some embodiments the postbiotic will be produced using one microbial strain and in others a mixture or cocktail of organisms will be used.
Suitably the carrageenan powder is made up in a cold-water slurry just prior to adding to the hot pot ale. The pot ale may be introduced into a collection vessel, and the carrageenan may then be added. The action of filling the collection vessel by pump agitates and mixes the carrageenan together with the pot ale. The pot ale may then pumped into a whirlpool tank. Whirlpool tanks are specialized cylindrical vessels with flat bottoms where liquids are precisely swirled to precipitate solids and accumulate them at the base of the tank. The addition of carrageenan assists in removing protein fractions in the pot ale, by binding to them in solution to form aggregates that are precipitated most quickly by whirlpooling. The carrageenan treated pot ale is left in the tank until the material has fully precipitated and cooled. The pot ale is then subjected to reverse osmosis to concentrate the whirlpool material for use as a fermentation medium. Suitably the reverse osmosis step concentrates the material by a factor of 5 -6.
Preferably, one or more of magnesium (about 0.2 g/L) and manganese (about 0.04 g/L) salts, tween surfactants (about 1 g/L) and nitrogen sources, such as protein hydrolysates (about 1-5 g/L), are added to the fermentation medium to promote lactic acid bacterial growth. Also preferably the pH, temperature and fermentation time are preferably all optimised depending on the microbial species being grown, as is well known to one of skill in the art.
In one particular embodiment seaweed filter cake is added to the fermentation medium. Seaweed filter cake is one of the waste materials generated from the manufacture of biostimulants such as seaweed extracts derived from the marine algae Ascophyllum nodusum. Supplementation with washed and dried SFC improves the cell titre in the fermentation step. Since the seaweed filter cake is a waste stream which typically contains polyphenols, the use of seaweed filter cake in the process allows the introduction of health promoting polyphenols into the final postbiotic product.
The fermentation mixtures may be further supplemented with protein hydrolysates (1-5% w/v). Suitable protein hydrolysates used for supplementing the fermentation medium may be selected from chickpea, fava bean and lentil protein concentrates.
In some embodiments the step (d) is performed as a primary or submerged fermentation. In other embodiments a secondary, solid-state fermentation is carried out on brewers spent grains, before the killing step (d). A liquid postbiotic product only requires primary/submerged fermentation whereas a solid postbiotic product will require both a primary/submerged and secondary/solid-state fermentation step.
Preferably after the heat killing step, the heat killed cells may be mixed with additional products such as Aquamin (available from Marigot Ltd), or milled seaweed, or a human foodstuff, an animal feed or a pet food product.
The invention also provides a postbiotic product whenever produced by a method as described above. Such postbiotic products have immunomodulatory activity, dampen inflammatory responses and induce innate immune training or memory. In particular the postbiotic products have immunomodulatory properties in that they can bring about an increase in ILIO levels and a decrease in TNFa levels.
Brief Description of the Drawings
Fig. 1. Malt whisky production and co-product generation.
Fig. 2. Growth of L. rhattmosity on Pot ale containing media Fig. 3 Effect of addition of SFC in pot ale concentrates on growth of L. rhamtiosus.
Fig. 4 Growth of different lactic acid bacterial strains on Pot ale medium Fig. 5. Growth of yeast on potale with/without additional nitrogen sources Fig. 6. Fermentation of whirlpool material (supplemented with Atura protein concentrates) by L. easel Fig. 7. Fermentation of pot ale concentrates (supplemented with protein hydrolysates and seaweed filter cake) by L. easel Fig. 8. Growth of L. rhamitosus on spent grain supplemented with salts/citric acid/skimmed milk powder Fig. 9. Growth of L.casei on spent grain supplemented with salts/citric acid/skimmed milk powder Fig. 10. Growth of L. hrevis on spent grain supplemented with salts/citric acid/skimmed milk powder Fig. 11. Growth of]?. aciddactici on spent grain supplemented with salts/citric acid/skimmed milk powder Fig. 12. Fermentation of spent grain (supplemented with carbohydrate fractions (5%) from Atura proteins) by L. casei Fig. 13. Fermentation of spent grain (supplemented with Atura protein (1%) concentrates) by L. easel Fig. 14. Fermentation of spent grain (supplemented with Atura protein (5%) concentrates) by L. case/
Detailed Description of the Drawings
Fermentation of pot ale Experiment 1: Use of pot ale concentrates as a nutrient source for Lactobacillus rhamnosus (L. rhamnosus) The aim of the experiment was to test pot ale concentrates as a sole nutrient source in L. rhamnosus fermentation, and to investigate the effect of addition of nitrogen and/or salts on pot ale concentrates in L. rhamnosus fermentation. In addition supplementation with another industrial by-product (wastes) was studied for its effect in L. Rhamnosus fermentation.
Material and methods: The pot ale was sourced from Lochranza distillery and was treated with Carrageenan in an (intermediate bulk container) IBC tank. Intermediate bulk containers are industrial-grade containers engineered for the mass handling, transport, and storage of liquids, semi-solids, pastes, or solids. The Carrageenan treated pot ale was run through a whirlpool to precipitate insoluble particles. The supernatant (whirlpool material) was then passed through reverse osmosis to concentrate up to the desired 5X concentrate. Cultures were grown using shake flask methodology in 100 mL Scott Duran bottles containing 50 ml medium (pH 5 -8) and incubated at 25 -40°C for 20-30 h with a slow agitation (40-60 rpm). Four shake flask experiments were conducted to test pot ale concentrates as a sole nutrient source in lactic acid fermentation and to investigate the effect of addition of nitrogen and/or salts on pot ale concentrates in lactic acid fermentation. The four shake flask experiments were as follows: 1. Pot Ale concentrates (control) 1 Pot Ale concentrates + Magnesium and Manganese salts + Tween 80 3. Pot Ale concentrates + Basal salt media (salts, citric acid, buffers) 4. Pot Ale concentrates + protein hydrolysates Results: Bacterial growth was better when pot ale was combined with nitrogen sources The addition of essential salts and nitrogen source had a positive impact on cell growth/count (Fig. 2).
Experiment 2: Effect of addition of seaweed filter cake (SFC) in pot ale concentrates and its effect on the growth of L. rhatnnosus The aim was to supplement pot ale medium with another industrial by-product (wastes) and study their effect in li. rhamnosus fermentation.
Material and methods: The methodology was the same as in Experiment 1 but the four shake flask experiments were as follows: 1. Pot ale concentrates containing medium -control 2. 1% dried SFC in Pot Ale concentrates 3. 2% dried SFC in Pot Ale concentrates 4. 3% dried SFC in Pot Ale concentrates 5. 4% dried SFC in Pot Ale concentrates Results: Supplementing the pot ale medium with SFC had a positive effect on cell growth/count (Fig. 3) Experiment 3: Use of pot ale concentrates as a nutrient source for lactic acid bacteria The objective of this study was to determine whether distillery concentrates could be used to grow lactic acid bacterium.
Materials and methods: The methodology was the generally the same as in Experiment 1 but the pot ale medium was maintained at pH 8.0. Inoculum developed on MRS broth and was added at 10% (v/v). Total viable counts (TVC); a serial dilution of fermented pot ale was carried out using 0.85% saline and 100 tl of culture/sample was spread on MRS agar plate. The bacterial cultures used were as follows: * Lactobacillus easel * Lactobacillus rhanmosus * Lactobacillus brerts* * Paediococcus acidilactici Results: All LAB strains grew well on pot ale concentrates. The highest TVC was obtained with L. case/ followed by L. rhamnosns, L. brevis and P. acidilactici (Fig. 4).
Experiment 4: Use of pot ale concentrates as a nutrient source for yeast fermentation The objective of this study was to determine whether pot ale could be used for yeast fermentation.
Material and methods: Cultures (Saccharomyces cerevisiae) were grown in Scott Duran bottle (100 ml) containing 50 ml pot ale medium (pH adjusted to 5.50) and incubated at 300C for 24 h with a slow agitation (80 rpm) The inoculum was developed on malt extract broth and was added at 10% (v/v).
Results: The highest TVC was obtained with the addition of yeast extract (3%), protein hydrolysates (3%) and yeast extract (1.5%) + protein hydrolysates (1.5%) as shown in Fig. 5.
Experiment 5. Fermentation of pot ale (whirlpool material) supplemented with protein concentrates (from Marigot Ltd. -Atura proteins) by L. cosei Material and Methods: The pot ale was sourced from Legg distillery and was treated with Carrageenan in an IBC tank. The Carrageenan treated pot ale was run through a whirlpool to precipitate insoluble particles.
The whirlpool fermentation was conducted with supplementation by chickpea and fava bean protein fractions (1.5/3%). Cultures were grown in Scott Duran bottle (100 ml) containing 50 ml medium (pH 8.0) supplemented with/without protein fractions and incubated at 37oC for 20-24 h with a slow agitation (100 rpm). The following shake flasks experiments were conducted: * Whirlpool material * Whirlpool material + Chickpea protein concentrates (1.5%) * Whirlpool material + Chickpea protein concentrates (3%) * Whirlpool material + Fava protein concentrates (1.5%) * Whirlpool material + Fava protein concentrates (3%) Total viable counts (TVC) were measured after 24 h. For TVC, a serial dilution was carried out using 0.85% saline and 100 R1 of culture/sample was spread on MRS agar plate.
Results: There was a significant increase (5-6-fold) in the cell counts when whirlpool material was fermented with protein supplements (Fig. 6) as compared to control. There was not much difference in the cell counts yield between 1.5% or 3% protein concentrates supplemented cultures.
Experiment 6: Use of pot ale concentrates as a growth medium for Aspergillits oryzae and enzyme production The purpose of this experiment is to see whether pot ale can be used as a medium to grow a filamentous fungus (24,spergillus oryzae) and produce industrially important enzymes.
Material and methods: Aspergilhis otyzae IMI 283862 maintained on potato dextrose agar (PDA) was used in this study. There were two stages involved in fungal fermentation.
1) lnoculum development A piece of (-1.5 cm) of fungal cultures from PDA plate was transferred into 50 ml of pot ale (concentrated (5X) using reverse osmosis) and the pH was adjusted to 5.5 Flasks were incubated at 30°C with an agitation (150 rpm) for 24 h. 2) Enzyme cocktails production Pot ale was supplemented with different inducers (chickpea, lentil, fava bean protein fractions) at 2% concentration and the pH was adjusted to 5.5. 10% (v/v) of inoculum developed on pot ale was used. Flasks were incubated at 30°C with an agitation (150 rpm) for 120 h. Fermented broth was centrifuged at 4000 rpm for 30 min and the supernatant was used for enzyme assays/concentration.
Enzyme cocktails were then concentrated using 10 kDa MWCO PES membrane. The following parameters were used.
Feed pump: 50 rpm Retentate pump: 40 rpm Retentate P2: 1.4 bar Initial volume: 550 ml Final volume: 58 ml Processing time: 12 h Concentration: -9.5-fold Results: Excellent fungal growth was observed in all pot ale materials. It is concluded that any type of pot ale materials can be used to grow A.spergillus oryzae. Significant amounts of different protease activities were measured in concentrated enzyme cocktail (Table 2) Endo ylanase activity Wien) X 61 p116 (0.11A sodium Xylanase standard control (2,41ilmn c2,..31. 23 OC.20E.3 pH4 510.1 sodium acetate phosphate buffer) Aspergiiluscocktaii neat a 77 0,27 buffer) Uirrit 9D Aspergillus cocktail concentrated 0.'to, 0,007 SD 2 34 026 Aapetigiiitleteriktaii perrneate 014 0036 97 ti 4 flat, 0.006 Endo celtulase activity (U/nti) pH43 (illNt sodium acetate pile 0.1M SOC/9191 buffer) phosphate buffer) Urriti SE) Ulm! SD ff 26 53 026 - .037 0.03 01 0003 0,002 CellulaSe Stan at Aspergefuecocktae neat Aspergilltis cocktail concentrated Aspergillue cock:ea permeate trol 0.0083 0.012 0.002 0.002 Betaglucanase activity pH 4.6 (0.04IY/ sodium cetate and 0 04M sodium phosphate) m:- SD Malt extract betagiticanase standarti tzlrii1J1Kg) Aspergilluscocktaii neat 0.002O 0002 Aspergillua cock:tali concentrated 0.003 0006 Aspercitiluscocl<tazi permeate 0001 0 0007 Table 2. Determination of enzyme activities in fungal enzyme cocktails ctivity (Wro9 6.5(0 Commercnii Neutra e( m Aspergiiius cocktail neat (Uimi) Astpergillus cocktail concentrated {Linn)) itspergnacocktaii permeate (Eitetil Freeze dried Sioorotease editing) Commercial Alcalase (Wm)} Aspergiairs cocktail neat. ttrimii Asperwilus cocktaa concentrated rtlann Aspernieue cocktail nemerato (Lem) freeze Prien Sioprotease (temp..) Commercial Savinase1lilml) AsperigiFuer-ocittaii neat iliern9 Aspergillus cocktail concentrated (1.11mt) litepergaitio cocktail permeate if: ml freeze dz*ed Bre:protegee (Utmg) 26.18 9 55 16.26 Ge 205 0.0092 0006 pH 7E (0.1 Mitts 11CL) 27.a/ 2? 1083 171 17.47 04 I 95 3.09 00176 0033 M sodium carbonate 1 sodium bicarbonate 40E6 057 32 0 51 634 077 I 25 03t 8 0 0051 pH 1001 Experiment 7: Use of pot ale concentrates as a nutrient source for Corptebacterium glutamictun The purpose of this experiment is to see whether we can use pot ale as a medium to grow Corynebacterium gitnamicum NCIMB 10025 which will be used to produce glutamate (umami flavour) Material and methods: The pot ale was sourced from Lochranza distillery and was treated with Carrageenan in an IBC tank. The Carrageenan treated pot ale was run through a whirlpool to precipitate insoluble particles. The supernatant (whirlpool material) was then passed through reverse osmosis to concentrate up to the desired 5X concentrate.
Cultures were grown in Scott Duran bottle (100 ml) containing 50 ml Pot Ale medium (pH adjusted to 5.50) and incubated at 30°C for 24 h with a slow agitation (80 rpm). The inoculum was developed on tryptic soy broth and was added at 10% (y/v).
Results: Initial studies conducted with Cl ghlianticum NCIMB 10025 showed that this bacterium grows on Pot ale concentrates and cell counts were slightly better than standard TSB/ NB media (Table 3). \\ .
* * * * * "k'k 'kkNkT%INV \k": ; x le-rok 06 mi-t N5-LochPotAe 143t4x TSB -Loch Pot Ale 160 ± 2 x 106 ml 64 ± 6 xlOml4 Table 3. Growth of C. glutamicum on Pot ale concentrates Experiment 8: Use of pot ale concentrates as a nutrient source for Prop/on/bacterium acidtproienonici The purpose of this experiment to see the growth of propionic acid producing bacteria on pot ale concentrates. Prop/on/bacterium acidipropionici NCIMB 8070 was purchased from NCIMB. Bacterial cultures were revived using Krebs' yeast lactate broth.
KREBS' YEAST LACTATE MEDIUM (KYL) tsiument Broth (cdontro0 Tr,sc, broth teoniroi) 63± x Yeast extract 10.0 KH2PO4 1.0 Na2HPO4.2H20 3.0 0 Sodium lactate (70%) 40.0 ml Distilled water 960.0 ml Preparation: **Adjust pH to 7.0. Autoclave at 121°C for 15 minutes.
After 48 h, broth cultures were streaked on KYL agar plates and incubated at 30°C in a sealed Anaerocult bags. Cultures were further confirmed for their purity.
Growth of P. acidipropionici NCIMB 8070 on pot ale concentrates The pot ale was sourced from Lochranza distillery and was treated with Can-ageenan in an IBC tank. The Carrageenan treated pot ale was run through a whirlpool to precipitate insoluble particles. The supernatant (whirlpool material) was then passed through reverse osmosis to concentrate up to the desired 5X concentrate. The pot ale concentrates (5X) was used a sole nutrient medium for growing Propionibacterium. The pH of pot ale was adjusted to 7.0 and then autoclaved. Experiments were conducted in a sterile airtight plastic container (150 ml). Inoculum developed on K YL broth (-36 h old) was used at 10% (v/v). Fermentation was stopped after 4 and 6 days of incubation. TVC and medium Total viable cell counts of 19 x 107per ml was obtained after 6 days. The medium pH was dropped from 7 to 5.9.
Volatile fatty acid (VFA) analysis Cell biomass was separated by centrifugation and the supernatant was acidified using ortho phosphoric acid. Samples were analyzed for VFA using GC-FED.
Sample 1: Fermentation was stopped after 6 days Sample 2: Fermentation was stopped after 4 days Total VFA (volatile fatty acids) was quantified as -16 g/L. Propionic acid and acetic acids were quantified as 5-5 -5.9 g/L and 7-8 g/L, respectively. In addition to major acids, other VFA's were also quantified at low level (Table 4).
Result 4 Days Result c Days Unit Propoaic Mtutylic thttpc 7.01 551 001 1.05 < 0.01 in giii ggfee: gilizfeginue 8111 5..92 0),ot OA 0..:.)2 014 glEitro. .g.Mrc :w4cproic 195 2.37.3. 0.13 16:3 64 e <OM il &tire gifilic 11?pti..;rn2:c. ,...iiiitinutt: o.ia &gill: ic-.1.0 lattii 01 164 gihtfe. OMR: tv.E^tcc..
Table 4. VFA produced by Propionibacterium acidiproponici fermentation of pot ale after 4 and 6 days Experiment 9: Effect of addition of protein hydrolysates and seaweed filter cake in pot ale concentrates and its effects on the growth of L. caw' Material and methods: The pot ale was sourced from Lochranza distillery and was treated with Carrageenan in an IBC tank. The Carrageenan treated pot ale was run through a whirlpool to precipitate insoluble particles. The supernatant (whirlpool material) was then passed through reverse osmosis to concentrate up to the desired 5X concentrate.
The pot ale concentrate fermentation was conducted with supplemented protein hydrolysates and seaweed filter cake derived from dried seaweed. Cultures were grown in Scott Duran bottle (100 ml) containing 50 ml medium (pH 8.0) supplemented with protein hydrolysates and seaweed filter cake derived from dried seaweed and incubated at 37°C for 20-24 h with a slow agitation (100 rpm).
Results: Supplementing the pot ale concentrate fermentations with protein hydrolysates and seaweed filter cake derived from dried seaweed increased the TVC. The highest TVC was obtained with the addition of protein hydrolysates + seaweed filter cake derived from dried seaweed, followed by the addition of protein hydrolysates alone (Fig 7).
Fermentation of brewers spent grain Experiment 10: Fermentation of brewers spent grain (BSG) using Lactobacillus easel Material and methods: Distillers spent grain was received from Laag Arran Distilleries. The bacterium used in this study was Lactobacillus easel. There were two stages involved in BSG fermentation.
1. Primary/Submerged fermentation Pot Ale concentrates were used a sole nutrient medium. L. easel cultures were grown in Scott Duran bottle (100 ml) containing 50 ml of Pot ale concentrates with an initial pH 8.0 (adjusted) and fermentation was conducted at 37°C for 24 h with a slow agitation (100 rpm).
2. Secondary/ solid state fermentation Secondary solid fermentation was conducted using sterilized fresh spent grain in a closed plastic container. Lactic acid bacterial cultures grown on Pot Ale concentrates (primary fermentation) was used as an inoculum at 10% (v/w) and fermentation was conducted at 37°C for 24 h. Results: Total viable cell counts were measured after 24 h in the fermented spent grain and the TVC counts were in the range of 5-10 x 107 g BSG. Fermented BSG was dried in an oven at 100°C for -36 h. In terms of taste, all fermented BSG are palatable.
Experiment 11: Fermentation of BSG using different lactic acid bacterial strains Bacterial cultures used: * Lactobacillus easel * Lactobacillus rhamno.sus * Lactobacillus breves * Paediococcus acidilactici Material and methods: There are two stages involved in spent grain fermentation. 1. Primary/Submerged fermentation Pot Ale concentrates (5X, RO) was used a sole nutrient medium. Lactic acid bacterial cultures were grown in Scott Duran bottle (100 ml) containing 50 ml of Pot ale concentrates with an initial pH 8.0/6.5 (adjusted) and fermentation was carried out at 37oC for 24 h with a slow agitation (80 rpm).
2. Secondary/ solid state fermentation Secondary solid fermentation was carried out using sterilized fresh spent grain. Lactic acid bacterial cultures grown on Pot Ale concentrates (primary fermentation) was used as an inoculum at 10% (v/w) and fermentation was carried out at 37oC for 24 or 48 h. To see the effect of addition of salts/citric acid/skimmed milk powder on cell titre and flavour enhancement, the following experiments were conducted.
* Spent grain * Spent grain + Salts * Spent grain + Citric acid (1%) * Spent grain + Citric acid (1%) + Salts * Spent grain + Skimmed milk powder (1%) * Spent grain + Skimmed milk powder (1%) + Salts Total viable cell counts were measured after 24 h in the fermented spent grain and the results are discussed individually below for each strain.
Results: Spent grain fermented by L. Casei L. easel showed an excellent growth on spent grain. Highest TVC (97 ± 2 x 107 8-1) was obtained on spent grain supplemented with skimmed milk powder with salts (Fig. 8). Cell counts in spent grain fermented in the presence of salts were slightly higher than control. Cell counts were lower in citric acid added samples (7 -25 x 105 g-1). Spent grain fermented by L. rhamnasus L. rhainnosus grew well on spent grain. TVC trend was quite similar to L. easel, TVC count was high in fermented spent grain with skimmed milk (60 ± 9 x 107 g4). However, TVC titre in citric acid added fermented sample was higher than L. easel. There was no significant difference in TVC between control and salts added samples (Fig. 9).
Spent grain fermented by L. brevis Growth performance of L. breves on spent grain was completely different from other LAB strains. TVC counts were higher in spent grain supplemented with only salts (37 ± 2 x io 4) followed by skimmed milk powder (25 ± 2 x 10 g-1). Interestingly, significant counts were observed on spent grain with citric acid added sample also (Fig. 10).
Spent grain fermented by Pediococcus aciddactici P. acidilactici showed good growth on spent grain. TVC counts (15 + 3 x 107 s-1) were slightly higher in spent grain supplemented with skimmed milk powder than control (Fig. 11). TVC counts were lower in spent grain fermented with citric acid. This is in confirmatory with other LAB strains.
Experiment 12. Fermentation of BSG supplemented with carbohydrate fractions (from Marigot Ltd -ATURA proteins) by L.casei Material and methods: Spent grain fermentation was carried out with supplementation of carbohydrate fractions (1%). The following experiments were carried out and TVC counts was measured after 24 h. * Spent grain + Salts * Spent grain + Lentil carbohydrate fraction (1%) * Spent grain + Fava carbohydrate fraction (1%) * Spent grain + Chickpea carbohydrate fraction (1%) Results: There was a significant increase in the cell counts in fermented BSG samples supplemented with 1% lentil, fava and chickpea carbohydrate fractions (Fig. 12) as compared to BSG with salts.
Experiment 13: Fermentation of BSG supplemented with 1% protein concentrates (from Marigot Ltd -ATURA proteins) by L. casei Material and methods: Spent grain fermentation was carried out with supplementation of protein concentrates (1%). The following experiments were carried out and TVC counts was measured after 24 h. * Spent grain * Spent grain + Salts * Spent grain + Chickpea protein (1%) * Spent grain + Fava protein (1%) * Spent grain + Lentil protein (1%) * Spent grain + Umami (1%) * Spent grain + Chickpea + Fava + Lentil + Umami (0.25% each) Results: There was a significant increase in the cell counts in fermented BSG samples supplemented with 1% lentil, fava, chickpea and umami protein concentrates (Fig 13) as compared to control.
Experiment 14: Fermentation of BSG supplemented with 5% protein concentrates (from Marigot Ltd -ATURA proteins) by L.Casei Material and methods: Spent grain fermentation was carried out with supplementation of protein concentrates (5%). The following experiments were carried out and TVC counts was measured after 24 h. * Spent grain * Spent grain + Salts * Spent grain + Chickpea protein concentrates (5%) * Spent grain + Fava protein concentrates (5%) * Spent grain + Lentil protein concentrates (5%) * Spent grain + Umami isolate (5%) Results: There was a significant increase in the cell counts in fermented BSG samples supplemented with 5% chickpea protein concentrates (Fig. 14) as compared to control.
Experiment 15: The effect of postbiotics on immune modulation (in vitro study); Materials and Methods The immunomodulatory and anti-inflamatory properties of the following postbiotics were determined:-Raw pot ale (Yeast postbiotic); Pot ale fermented with Lactobacillus casei (Lactic acid bacteria postbiotic), and Pot ale fermented with Aspergillus oryzae (Fungus postbiotic).
Cell toxicity studies were carried out using standard methods. Raw blue mouse line wasused as a reporter cell line for Quanti-blue assay to measure TFN-alpha and IL 10. Results: These postbiotics showed the ability to increase levels of 11_10 and decrease levels of TFNa in vitro.
The words "comprises/comprising" and the words "having/including" when used herein with reference to the present invention are used to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination.
Claims (17)
- Claims I. A method of producing a postbiotic comprising the steps: (a) obtaining a liquid pot ale from the production of whisky in the absence of enzymes, (b) concentrating the pot ale by reverse osmosis using a membrane with a pore size of about 0.0002 micron or less osmosis to produce a fermentation medium, (c) inoculating the raw, concentrated pot ale from step (b) with one or more probiotic bacterial and/or yeast and/or fungal strains, (d) incubating the inoculated pot ale at a temperature which is appropriate to promote growth of the particular bacterial, yeast or fungal strains used in step (c), (e) raising the temperature of the incubated pot ale of step (d) to a temperature sufficient to kill the bacterial, yeast or fungal strains.
- 2. A method as claimed in claim 1 wherein the reverse osmosis membrane has a pore size of about 0.0001 micron or less.
- 3 A method as claimed in claim 1 or 2 wherein the liquid pot ale is clarified before concentration in step (b) by mixing it with an aqueous solution of carrageenan.
- 4. A method as claimed in claim 3 wherein the carrageenan powder is made up in a cold-water slurry just prior to adding to hot pot ale.
- 5. A method as claimed in claim 1 or 2 wherein the pot ale is clarified by centrifugation.
- 6. A method as claimed in any preceding claim wherein the bacterial, yeast or fungal strains are selected from homofennentative and heterofennentative lactic acid bacterial group Lactobacillus species., Paediococcus species. Aspergillus species, Saccharoinyces species, Propionicbacterium species, Corynebacterium species and the Lactic acid bacterial strains (EFSA approved):-Lactobacillus case, Lactobacillus rhainnosus, Lactobacillus breves -2 strains, Paediococcu.s pentosacems -3 strains, Paediococcus acidilactici, Lactobacillus rhainnosus, Lactobacilhis ferinentum, Lactobacillus plantar= -3 strains, Lactobacillus paracasei, Paediococcus parvulus, Lactobacillus buchneri -2 strains, and Enetrococcus faccium.
- 7. A method as claimed in any preceding claim wherein the mixture is subjected to whirlpooling to clarify the pot ale.
- 8 A method as claimed in claim 7 wherein the whirlpooled material is then subjected to reverse osmosis to concentrate for use as a fermentation medium
- 9. A method as claimed in any preceding claim wherein one or more of salts, surfactants and nitrogen sources are added to the fermentation medium.
- 10. A method as claimed in any preceding claim wherein seaweed filter cake is added to the fermentation medium.
- 11 A method as claimed in any preceding claim wherein the fermentation mixture is further supplemented with yeast extract, and/or protein hydrolysates.
- 12. A method as claimed in claim 10 wherein the protein hydrolysate is selected from chickpea, fava bean and lentil protein concentrates.
- 13. A method as claimed in any preceding claim wherein the step (d) is performed as a primary or submerged fermentation.
- 14. A method as claimed in any preceding claim wherein further comprising a secondary, solid-state fermentation carried out on brewers spent grains, before the killing step (d).
- 15. A method as claimed in any preceding claim wherein after the heat killing step, the heat killed cells are mixed with additional products such as Aquamin, milled seaweed, a foodstuff, an animal feed or a pet food product.
- 16. A postbiotic product whenever produced by a method as claimed in any preceding claim.
- 17. A postbiotic product as claimed in claim 16 having immunomodulatory properties such that they ring about an increase in IL10 levels and a decrease in TNFa levels.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2219520.0A GB2625740A (en) | 2022-12-22 | 2022-12-22 | The production of postbiotics from fermented pot ale and brewers spent grain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2219520.0A GB2625740A (en) | 2022-12-22 | 2022-12-22 | The production of postbiotics from fermented pot ale and brewers spent grain |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202219520D0 GB202219520D0 (en) | 2023-02-08 |
GB2625740A true GB2625740A (en) | 2024-07-03 |
Family
ID=85130051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2219520.0A Pending GB2625740A (en) | 2022-12-22 | 2022-12-22 | The production of postbiotics from fermented pot ale and brewers spent grain |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2625740A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1602459A (en) * | 1978-05-12 | 1981-11-11 | Distillers Co Yeast Ltd | Process for the treatment of food and fermentation effluents |
US20180343891A1 (en) * | 2017-06-01 | 2018-12-06 | Chie Ying Lee | System for and a method of producing enriched and digested probiotic super feed using wet mill and dry mill processes |
US20210059277A1 (en) * | 2016-06-20 | 2021-03-04 | Lee Tech Llc | System for and method of making four types of animal feeds from grains that are used in the alcohol production plant |
JP2022161045A (en) * | 2021-04-08 | 2022-10-21 | 有限会社環境テクシス | Production method of feed |
-
2022
- 2022-12-22 GB GB2219520.0A patent/GB2625740A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1602459A (en) * | 1978-05-12 | 1981-11-11 | Distillers Co Yeast Ltd | Process for the treatment of food and fermentation effluents |
US20210059277A1 (en) * | 2016-06-20 | 2021-03-04 | Lee Tech Llc | System for and method of making four types of animal feeds from grains that are used in the alcohol production plant |
US20180343891A1 (en) * | 2017-06-01 | 2018-12-06 | Chie Ying Lee | System for and a method of producing enriched and digested probiotic super feed using wet mill and dry mill processes |
JP2022161045A (en) * | 2021-04-08 | 2022-10-21 | 有限会社環境テクシス | Production method of feed |
Also Published As
Publication number | Publication date |
---|---|
GB202219520D0 (en) | 2023-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105132322B (en) | One lactobacillus plantarum and application thereof | |
CN102191202B (en) | High-density culture method for lactic acid bacteria | |
CN101074426B (en) | Method for producing bean-dregs feed containing conjugated linolic acid by plant lactobacillin fermentation | |
CN103468594B (en) | Candidautilis strain and application thereof | |
CN104651268A (en) | Lactobacillus plantarum and application thereof | |
CN104106726A (en) | New probiotic, and probiotic fermentation feed prepared by using it | |
KR101349692B1 (en) | The Alcohol resistant strain of lactic acid bacteria, Pediococcus acidilactici and its use | |
CN113549574B (en) | Bacillus coagulans and application thereof | |
CN105176874A (en) | Bacillus coagulans fm 603 and application thereof | |
CN110063406A (en) | Bacillus amyloliquefaciens and its fermentation seed liquid, application and soybean meal fermenting method | |
CN116083262A (en) | Lactobacillus plantarum strain with aquatic pathogenic bacteria antagonistic property and preparation and application of preparation thereof | |
CN105132321A (en) | Enterococcus faecium, culture medium thereof for high-density solid-state fermentation, and high-density solid-state fermentation method | |
CN111534459A (en) | Lactobacillus fermentum for high yield of amylase and application of lactobacillus fermentum in preparation of fermented feed | |
CN103525724A (en) | Microbial leavening agent of cottonseed meal as well as preparation method thereof | |
CN107043722A (en) | One plant of pig source lactobacillus reuteri and its solid-state probiotics of preparation | |
CN113980853B (en) | Lactic acid-producing lactococcus garvieae WBT0008 and application thereof | |
CN108546663B (en) | Porcine lactobacillus crispatus and application thereof | |
KR20120121282A (en) | Method for preparing pork cutlet using capsosiphon fulvescens | |
KR101665334B1 (en) | Rhodobacter sphaeroides CB 8521 strain, having the effect of reducing malodor and immune activity in livestock industry, and microbial agent using it | |
CN116064281B (en) | Bacillus bailii and application thereof in low-salt fermentation of food | |
Furuta et al. | Utilization of fermented barley extract obtained from a by-product of barley shochu for nisin production | |
KR20080078460A (en) | Novel lactrobacillus buchneri and use thereof | |
GB2625740A (en) | The production of postbiotics from fermented pot ale and brewers spent grain | |
CN112391317B (en) | Probiotic bacterial strain composition for producing cubilose acid and application | |
Michalak et al. | Functional fermented food and feed from seaweed |